Lung Cancer, Nonsmall Cell, Stage I Recruiting Phase 2 Trials for Pembrolizumab (DB09037)

Also known as: NSCLC, Stage I / Stage I NSCLC / Stage I Non-Small Cell Lung Cancer / Non-small Cell Lung Cancer Stage I / Lung cancer non-small cell stage I

IndicationStatusPhase
DBCOND0081601 (Lung Cancer, Nonsmall Cell, Stage I)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04317534Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cmTreatment